The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.
Open accessAbstract
Chylomicrons have been shown to protect mice and rats against a lethal dose of lipopolysaccharide and may serve as a therapeutic means to protect against endotoxemia. However, the requisite of isolation from human lymph hampers pharmaceutical application. Recently, we developed recombinant chylomicrons from commercially available lipids and human recombinant apolipoprotein E. The current study explored the effectiveness of these apoE-enriched emulsions in redirecting LPS from Kupffer cells to liver parenchymal cells. Upon injection into rats, 125I-LPS rapidly and specifically associated with the liver (64.3+/-3.1% of the injected dose) and spleen (4.1+/-0.7%). The uptake of LPS by the spleen was four- to fivefold reduced upon incubation with the apoE-enriched emulsion or free apoE (P < 0.0001), but not with emulsion alone or Lipofundin. Within the liver, 125I-LPS mainly associated with Kupffer cells. The uptake by Kupffer cells was eight- to ninefold reduced by the apoE-enriched emulsion or apoE alone (P < 0.01), and a 19.6-fold increased uptake ratio by liver parenchymal cells over Kupffer cells was observed. The emulsion without apoE had no effect on the in vivo kinetics of LPS. LPS interacted selectively with the apoE moiety of the recombinant chylomicron. Emulsion-associated and free apoE bound approximately two molecules of LPS, possibly by its exposed hydrophilic domain involving arginine residues. We anticipate that the protecting effect of endogenous chylomicrons against LPS-induced endotoxemia may result from the apoE moiety and that human recombinant apoE may serve as a therapeuticum to protect against endotoxemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“apoE was involved in the direct binding of lipopolysaccharide, the main toxic component of gram-negative bacteria [ 36], thereby decreasing the inflammatory response to lipopolysaccharide [ 37].”
From ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age (2006) · cites this paper as [36]
Experimental — accuracy not yet measuredIn the citing paper
“Endotoxin binds directly to APOE”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [81]
In the citing paper
“Thus, there is a clear and direct link between APOE variants and endotoxin.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986
Pathogenetic Mechanisms of Septic Shock
Epstein, F. H., & Parrillo, J. E. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282008 · Cited by 1,548
Cachectin: More Than a Tumor Necrosis Factor
Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,423
Parrillo, J. E., Parker, M. M., Natanson, C., Suffredini, A. F., Danner, R. L., Cunnion, R. E., & Ognibene, F. P. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-3-227 · Cited by 1,188
Waage, A., Brandtzaeg, P., Halstensen, A. I., Kierulf, P., & Espevik, T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.1.333 · Cited by 1,175
Blouin, A., Bolender, R. P., & Weibel, E. R. (1977) · The Journal of Cell Biology · doi:10.1083/jcb.72.2.441 · Cited by 879
Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides
Morrison, D. C., & Jacobs, D. M. (1976) · Immunochemistry · doi:10.1016/0019-2791(76)90181-6 · Cited by 819
Karkhanis, Y. D., Zeltner, J. Y., Jackson, J. J., & Carlo, D. J. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90260-9 · Cited by 704
In vivo protection against endotoxin by plasma high density lipoprotein.
Levine, D. M., Parker, T. S., Donnelly, T. M., Walsh, A., & Rubin, A. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12040 · Cited by 485
Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., & Wright, S. D. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.1025 · Cited by 442
Cited by
Sorted by citations
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
van Amersfoort, E. S., van Berkel, T. J. C., & Kuiper, J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.379-414.2003 · Cited by 755
Self-citationDyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492
The endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages
Baitsch, D., Bock, H. H., Engel, T., Telgmann, R., Müller‐Tidow, C., Varga, G., Bot, M., Herz, J., Robenek, H., von Eckardstein, A., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.222745 · Cited by 361
Gut microbiota and diabetes: from pathogenesis to therapeutic perspective
Burcelin, R., Sérino, M., Chabo, C., Blasco‐Baqué, V., & Amar, J. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0333-6 · Cited by 270
Whitten, M. M. A., Tew, I., Lee, B. L., & Ratcliffe, N. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2177 · Cited by 222
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K., Biessen, E. A. L., & van Berkel, T. J. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00109-0 · Cited by 217
Self-citationde Bont, N., Netea, M. G., Demacker, P. N. M., Verschueren, I., Kullberg, B. J., van Dijk, K. W., van der Meer, J. W. M., & Stalenhoef, A. F. H. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32147-7 · Cited by 210
APOε4 is associated with enhanced in vivo innate immune responses in human subjects
Gale, S. C., Gao, L., Mikacenic, C., Coyle, S. M., Rafaels, N., Murray Dudenkov, T., Madenspacher, J. H., Draper, D. W., Ge, W., Aloor, J. J., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.01.032 · Cited by 202
Lipopolysaccharide (LPS)-Binding Protein Mediates LPS Detoxification by Chylomicrons
Vreugdenhil, A. C. E., Rousseau, C. H., Härtung, T., Greve, J. W. M., Veer, C. V. ′., & Buurman, W. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1399 · Cited by 206
Wu, A., Hinds, C., & Thiemermann, C. (2004) · Shock · doi:10.1097/01.shk.0000111661.09279.82 · Cited by 203
Gut microbiota and immune crosstalk in metabolic disease
Burcelin, R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.016 · Cited by 195
Guerville, M., & Boudry, G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00098.2016 · Cited by 195
Apolipoprotein E Protects Against Bacterial Lipopolysaccharide-induced Lethality
Van Oosten, M., Rensen, P. C. N., Van Amersfoort, E. S., Van Eck, M., Van Dam, A.-M., Brevé, J. J. P., Vogel, T., Panet, A., Van Berkel, T. J. C., & Kuiper, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009915200 · Cited by 186
Self-citationLipoproteins in inflammation and sepsis. I. Basic science
Murch, O., Collin, M., Hinds, C., & Thiemermann, C. (2006) · Intensive Care Medicine · doi:10.1007/s00134-006-0432-y · Cited by 179
Apolipoprotein E Suppresses the Type I Inflammatory Response In Vivo
Ali, K., Middleton, M. K., Puré, E., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000187467.67684.43 · Cited by 179
Barlage, S., Gnewuch, C., Liebisch, G., Wolf, Z., Audebert, F., Glück, T., Fröhlich, D., Krämer, B. K., Rothe, G., & Schmitz, G. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1609-y · Cited by 174
Cuaz‐Pérolin, C., Billiet, L., Baugé, E., Copin, C., Scott‐Algara, D., Genze, F., Büchele, B., Syrovets, T., Simmet, T., & Rouis, M. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.155606 · Cited by 171
Cai, L., Ji, A., de Beer, F. C., Tannock, L. R., & van der Westhuyzen, D. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci31539 · Cited by 167
Vreugdenhil, A. C. E., Snoek, A. M. P., Veer, C. V. ′., Greve, J.-W. M., & Buurman, W. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10832 · Cited by 166
Ostos, M. A., Recalde, D., Zakin, M. M., & Scott‐Algara, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02692-3 · Cited by 152
Changes in the concentration and composition of plasma lipoproteins during the acute phase response
Carpentier, Y. A., & Scruel, O. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200203000-00006 · Cited by 148
Apolipoproteins modulate the inflammatory response to lipopolysaccharide
Berbée, J. F. P., Havekes, L. M., & Rensen, P. C. N. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35215 · Cited by 148
Self-citationLipoproteins inhibit macrophage activation by lipoteichoic acid
Grünfeld, C., Marshall, M. K., Shigenaga, J. K., Moser, A. H., Tobias, P. S., & Feingold, K. R. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33363-0 · Cited by 143
Immuno-microbiota cross and talk: The new paradigm of metabolic diseases
Burcelin, R., Garidou, L., & Pomié, C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2011.11.011 · Cited by 148
The endotoxin hypothesis of Alzheimer’s disease
Brown, G. C., & Heneka, M. T. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00722-y · Cited by 148
Yao, X., Gordon, E. M., Figueroa, D. M., Barochia, A. V., & Levine, S. J. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0060tr · Cited by 136
ApoE Plasma Levels and Risk of Cardiovascular Mortality in Old Age
Mooijaart, S. P., Berbée, J. F. P., van Heemst, D., Havekes, L. M., de Craen, A. J. M., Slagboom, P. E., Rensen, P. C. N., & Westendorp, R. G. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030176 · Cited by 129
Self-citationKitchens, R. L., Thompson, P. A., Munford, R. S., & O’Keefe, G. E. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300228-jlr200 · Cited by 123
Recalde, D., Ostos, M. A., Badell, E., García-Otín, A. L., Pidoux, J., Castro, G. R., Zakin, M. M., & Scott‐Algara, D. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000119353.03690.22 · Cited by 116
Detoxifying endotoxin: time, place and person
Munford, R. S. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x35161 · Cited by 152
Triglyceride-Rich Lipoproteins as Agents of Innate Immunity
Barcia, A. M., & Harris, H. W. (2005) · Clinical Infectious Diseases · doi:10.1086/432005 · Cited by 97
Yao, X., Fredriksson, K., Yu, Z., Xu, X., Raghavachari, N., Keeran, K. J., Nugent, G. Z., Kwak, M., Amar, M. J., Remaley, A. T., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201002-0308oc · Cited by 95
Reduction of Circulating Cholesterol and Apolipoprotein Levels during Sepsis
Fraunberger, P., Schaefer, S., Werdan, K., Walli, A. K., & Seidel, D. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.059 · Cited by 94
Review: The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity
Harris, H. W., Gosnell, J. E., & Kumwenda, Z. L. (2000) · Journal of Endotoxin Research · doi:10.1177/09680519000060060301 · Cited by 93
On the role and fate of LPS-dephosphorylating activity in the rat liver
Tuin, A., der Vlag, A. H., van Loenen-Weemaes, A. M., Meijer, D. K. F., & Poelstra, K. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00147.2005 · Cited by 91
Advances in Intravenous Lipid Emulsions
Carpentier, Y., & Dupont, I. E. (2000) · World Journal of Surgery · doi:10.1007/s002680010267 · Cited by 83
Endogenous carriers and ligands in non-immunogenic site-specific drug delivery
Vyas, S. P., & Sihorkar, V. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00067-3 · Cited by 82
Jiang, Q., DeTolla, L. J., van Rooijen, N., Singh, I. S., Fitzgerald, B., Lipsky, M. M., Kane, A. S., Cross, A. S., & Hasday, J. D. (1999) · Infection and Immunity · doi:10.1128/iai.67.4.1539-1546.1999 · Cited by 79
Berbée, J. F. P., van der Hoogt, C. C., Kleemann, R., Schippers, E. F., Kitchens, R. L., van Dissel, J. T., Bakker‐Woudenberg, I. A. J. M., Havekes, L. M., & Rensen, P. C. N. (2006) · The FASEB Journal · doi:10.1096/fj.05-5639fje · Cited by 81
Self-citationLipopolysaccharide-binding molecules: transporters, blockers and sensors
Chaby, R. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4020-4 · Cited by 79
Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation
Al‐Yafeai, Z., Yurdagul, A., Peretik, J. M., Alfaidi, M., Murphy, P. A., & Orr, A. W. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311705 · Cited by 78
Learning from biology: synthetic lipoproteins for drug delivery
Huang, H., Cruz, W., Chen, J., & Zheng, G. (2014) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1308 · Cited by 75
Apolipoprotein E‐deficient mice have an impaired immune response to Klebsiella pneumoniae
Bont, D., Netea, Demacker, Kullberg, Meer, V. D., & Stalenhoef (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00715.x · Cited by 71
Infection and Alzheimer's Disease: The APOE ε4 Connection and Lipid Metabolism
Urosevic, N., & Martins, R. N. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13407 · Cited by 68
Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes
Shao, B., Munford, R. S., Kitchens, R., & Varley, A. W. (2012) · Innate Immunity · doi:10.1177/1753425912442431 · Cited by 55
Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection
Hennig, B. J., Hellier, S. C., Frodsham, A. J., Zhang, L., Klenerman, P., Knapp, S., Wright, M., Thomas, H. C., Thursz, M. R., & Hill, A. V. S. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363883 · Cited by 65
Li, L., Thompson, P. A., & Kitchens, R. L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800172-jlr200 · Cited by 63
Walley, K. R., Francis, G. A., Opal, S. M., Stein, E. A., Russell, J. A., & Boyd, J. H. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0876ci · Cited by 58
Endogenous lipoproteins impact the response to endotoxin in humans
Harris, H. W., Johnson, J. A., & Wigmore, S. J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200201000-00004 · Cited by 56
Kitchens, R. L., & Thompson, P. A. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090020701 · Cited by 52
de Azevedo, O. G. R., Bolick, D. T., Roche, J. K., Pinkerton, R., Lima, A. Â. M., Vitek, M. P., Warren, C. A., Oriá, R. B., & Guerrant, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089562 · Cited by 51
de Haas, C. D., van der Zee, R., Benaissa-Trouw, B., van Kessel, K. V., Verhoef, J., & van Strijp, J. V. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2790-2796.1999 · Cited by 51
Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis
de Azevedo, O. G. R., Oliveira, R. A. C., Oliveira, B. C., Zaja‐Milatovic, S., de Araújo, C. V., Wong, D. V. T., Costa, T. B., Lucena, H. B. M., Lima‐Júnior, R. C. P., Ribeiro, R. A., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-35 · Cited by 46
Goldfarb, R. D., Parker, T. S., Levine, D. M., Glock, D., Akhter, I., Alkhudari, A., McCarthy, R. J., David, E. M., Gordon, B. R., Saal, S. D., et al. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00285.2002 · Cited by 44
Host defenses against metabolic endotoxaemia and their impact on lipopolysaccharide detection
Faraj, T. A., McLaughlin, C. L., & Erridge, C. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1280483 · Cited by 46
Shao, Y., Zhao, T., Zhang, W., He, J., Lu, F., Cai, Y., Lai, Z., Wei, N., Liang, C., Liu, L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-72616-0 · Cited by 43
Thompson, P. A., Berbée, J. F. P., Rensen, P. C. N., & Kitchens, R. L. (2008) · Innate Immunity · doi:10.1177/1753425908099171 · Cited by 41
Self-citationA Novel Role for CETP as Immunological Gatekeeper: Raising HDL to Cure Sepsis?
Blauw, L. L., Wang, Y., van Dijk, K. W., & Rensen, P. C. N. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.01.003 · Cited by 40
Self-citationRomanovsky, A. A., Ivanov, A. I., Lenczowski, M. J. P., KULCHITSKY, V. A., van Dam, A., Poole, S., HOMER, L. D., & Tilders, F. J. H. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00232-0 · Cited by 39
Hara, T., Ishida, T., Kojima, Y., Tanaka, H., Yasuda, T., Shinohara, M., Toh, R., & Hirata, K. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m008417 · Cited by 38
Thompson, P. A., Gauthier, K. C., Varley, A. W., & Kitchens, R. L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007435 · Cited by 36
Saita, D., Ferrarese, R., Foglieni, C., Esposito, A., Canu, T., Perani, L., Ceresola, E. R., Visconti, L. M., Burioni, R., Clementi, M., et al. (2016) · Scientific Reports · doi:10.1038/srep29353 · Cited by 36
Triglycerides Potentiate the Inflammatory Response in Rat Kupffer Cells
Budick-Harmelin, N., Dudás, J., Demuth, J. E., Madar, Z., Ramadori, G. P., & Tirosh, O. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1876 · Cited by 36
APOE Genotype Affects Outcome in a Murine Model of Sepsis: Implications for a New Treatment Strategy
Wang, H., Christensen, D. J., Vitek, M. P., Sullivan, P. M., & Laskowitz, D. T. (2009) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0903700111 · Cited by 34
Endotoxin promotes preferential periportal upregulation of VLDL secretion in the rat liver
Aspichueta, P., Pérez, S., Ochoa, B., & Fresnedo, O. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500003-jlr200 · Cited by 32
Araújo, C. V., Lazzarotto, C. R., de Aquino, C. C., Figueiredo, Í. L., Costa, T. B., Alves, L. G. R. D. D. S. E., Ribeiro, R. A., Bertolini, L. R., Lima, A. Â. M., Brito, G. A. D. C., et al. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20144360 · Cited by 29
Yang, Y., Fu, Q., Zhou, T., Li, Y., Liu, S., Zeng, Q., Wang, X., Jin, Y., Tian, C., Qin, Z., et al. (2016) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2016.09.007 · Cited by 28
Liver X Receptor Alpha Associates With Human Life Span
Mooijaart, S. P., Kuningas, M., Westendorp, R. G. J., Houwing‐Duistermaat, J. J., Slagboom, P. E., Rensen, P. C. N., & van Heemst, D. (2007) · The Journals of Gerontology Series A · doi:10.1093/gerona/62.4.343 · Cited by 28
Self-citationHepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice
van Diepen, J. A., Wong, M. C., Guigas, B., Bos, J. E., Stienstra, R., Hodson, L., Shoelson, S. E., Berbée, J. F. P., Rensen, P. C. N., Romijn, J. A., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m010405 · Cited by 26
Self-citationPlasma Apolipoprotein CI Protects Against Mortality From Infection in Old Age
Berbée, J. F. P., Mooijaart, S. P., de Craen, A. J. M., Havekes, L. M., van Heemst, D., Rensen, P. C. N., & Westendorp, R. G. J. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.2.122 · Cited by 25
Self-citationTyrosine fluorescence analysis of apolipophorin III–lipopolysaccharide interaction
Leon, L. J., Pratt, C. C., Vásquez, L. J., & Weers, P. M. M. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.05.009 · Cited by 24
An expanding role for apolipoprotein E in sepsis and inflammation
Chuang, K., Elford, E. L., Tseng, J., Leung, B., & Harris, H. W. (2010) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2009.10.017 · Cited by 24
NKT Cells: The Culprits of Sepsis?
Leung, B., & Harris, H. W. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.09.038 · Cited by 23
Schippers, E. F., Berbée, J. F. P., Disseldorp, I. M. L.-V., Versteegh, M. I. M., Havekes, L. M., Rensen, P. C. N., & van Dissel, J. T. (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1077-9 · Cited by 22
Self-citationBas, S., James, R. W., & Gabay, C. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-46 · Cited by 19
[Retracted] NKT Cells in Sepsis
Leung, B., & Harris, H. W. (2010) · Journal of Immunology Research · doi:10.1155/2010/414650 · Cited by 19
RetractedMicrobiote intestinal et dialogue immunitaire au cours de la maladie métabolique
Burcelin, R. (2017) · Biologie Aujourd hui · doi:10.1051/jbio/2017008 · Cited by 19
Lanza‐Jacoby, S., Miller, S., Jacob, S., Heumann, D., Minchenko, О. H., & Flynn, J. T. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090060701 · Cited by 18
Clinical use of lipid emulsions
Dupont, I. E., & Carpentier, Y. (1999) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199903000-00008 · Cited by 18
Rathnayake, S. S., Mirheydari, M., Schulte, A. T., Gillahan, J. E., Gentit, T., Phillips, A., Okonkwo, R. K., Burger, K. N. J., Mann, E. K., Vaknin, D., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.09.020 · Cited by 16
Kulminski, A. M., Barochia, A. V., Loika, Y., Raghavachari, N., Arbeev, K. G., Wojczynski, M. K., Thyagarajan, B., Vardarajan, B. N., Christensen, K., Yashin, A. I., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206873 · Cited by 16
Modulation of apolipoprotein E and interleukin-1β in the aging liver
Gee, J. R., Ding, Q., & Keller, J. N. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.01.010 · Cited by 16
Apolipoproteins as context-dependent regulators of lung inflammation
Figueroa, D. M., Gordon, E. M., Yao, X., & Levine, S. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813553-2.00013-0 · Cited by 15
Freitas, R. S., Roque, C. R., Matos, G. A., Belayev, L., de Azevedo, O. G. R., Alvarez-Leite, J. I., Guerrant, R. L., & Oriá, R. B. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab063 · Cited by 13
Sharifov, O. F., Nayyar, G., Ternovoi, V. V., Palgunachari, M. N., Garber, D. W., Anantharamaiah, G. M., & Gupta, H. (2013) · Innate Immunity · doi:10.1177/1753425913514621 · Cited by 12
Fuijkschot, W. W., Morrison, M. C., Zethof, I. P. A., Krijnen, P. A. J., Kleemann, R., Niessen, H. W. M., & Smulders, Y. M. (2017) · Shock · doi:10.1097/shk.0000000000001026 · Cited by 11
Effect of LPS on basal and induced apo E secretion by 25‐OH chol and 9cRA in differentiated CaCo‐2
Piquer, B. R., Nazih, H., Neunlist, M., Huvelin, J., & Bard, J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10786 · Cited by 11
Bazaz, R., Marriott, H. M., Wright, C., Chamberlain, J., West, L. E., Gelsthorpe, C., Heath, P. R., Maleki-Dizaji, A., Francis, S., & Dockrell, D. H. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1090550 · Cited by 10
High-density lipoprotein: a biomarker and therapeutic target in sepsis
Li, M., Barros-Pinkelnig, M., Arbous, M. S., Christoffersen, C., Rensen, P. C. N., & Kooijman, S. (2025) · Critical Care · doi:10.1186/s13054-025-05702-2 · Cited by 11
Self-citationFleischer, J. G., Rossignol, D., Francis, G. A., Chan, T., Lynn, M., & Wasan, K. M. (2011) · Innate Immunity · doi:10.1177/1753425910394395 · Cited by 9
Induction of cytokine tolerance requires internalization of Chylomicron-Bound LPS into hepatocytes
Kasravi, F. B., Brecht, W. J., Weisgraber, K. H., & Harris, H. W. (2003) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00197-5 · Cited by 9
Microbiota and Alzheimer’s disease: mechanistic insights from a multi-organ perspective
Liao, J., Mou, H., Luo, S., Shen, L., & Jiao, B. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00541-9 · Cited by 11
Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases
Fukuda, R., & Murakami, T. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00858 · Cited by 8
Hoekstra, M., van der Sluis, R. J., Hildebrand, R. B., Lammers, B., Zhao, Y., Praticò, D., van Berkel, T. J. C., Rensen, P. C. N., Kooijman, S., Jauhiainen, M., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313862 · Cited by 8
Self-citationLipoprotein-bound LPS induces cytokine tolerance in hepatocytes
Harris, H. W., & Kasravi, F. B. (2003) · Journal of Endotoxin Research · doi:10.1177/09680519030090010501 · Cited by 7
The effect of poloxamer 407 on the functional properties of HDL in mice
Yasuda, T., Johnston, T. P., Shinohara, M., Inoue, M., & Ishida, T. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01444.x · Cited by 6
Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock
van Amersfoort, E. S., & Kuiper, J. (2007) · CRC Press eBooks · doi:10.3109/9781420020595-21 · Cited by 6
Self-citationAkahane, S., Matsuura, H., Kaido, T., Usami, Y., Ishimine, N., Uehara, T., & Yamauchi, K. (2024) · Biological Chemistry · doi:10.1515/hsz-2024-0018 · Cited by 5
Apolipoprotein E3 and E4 isoforms exhibit differing effects in countering endotoxins
Puthia, M., Marzinek, J. K., Veselá, K., Larsson, A., Schmidtchen, A., Bond, P. J., & Petrlová, J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108236 · Cited by 5
Metadata
- Authors
- Rensen, P. C., Oosten, M., Bilt, E., Eck, M., Kuiper, J., & Berkel, T. J.
- Affiliations
- Leiden University (NL)
- Venue
- Journal of Clinical Investigation
- Published
- 1997-05-15
- Volume
- 99
- Issue
- 10
- Pages
- 2438-2445
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC508084
- OpenAlex
- W2044756436
- Cited by
- 113
- References
- 50
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 5 · 2013: 2 · 2012: 4
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- apolipoprotein E, lipopolysaccharide, endotoxemia, Kupffer cells, liver parenchymal cells, spleen, arginine residues
- MeSH terms
- Animals, Apolipoproteins E, Drug Combinations, Emulsions, Humans, Iodine Radioisotopes, Kupffer Cells, Lipopolysaccharides, Liver, Male, Metabolic Clearance Rate, Phospholipids, Recombinant Proteins, Sorbitol, Spleen, Tissue Distribution, Rats, Wistar, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review